Julia J Unternaehrer

12PUBLICATIONS
19CO-AUTHORS
Innate immunityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 29, 2026
Cancer cell-intrinsic type 1 interferon: production, signaling, and outcomes within sex-biased, female malignancies.

|Jul 10, 2026
Interferon beta drives therapy resistance in a patient-derived model of high-grade serous ovarian cancer.

|Jun 26, 2026
Multi-Omics Analysis Reveals Chronic Cisplatin Exposure Is Associated with Metabolic Rewiring Toward Glutathione Metabolism to Support Redox Adaptation in High-Grade Serous Ovarian Cancer.

|Oct 15, 2025
The GR-LEDGF/p75-HSP27 Axis Contributes to Cross-Resistance Between Enzalutamide and Docetaxel in Prostate Cancer.

Pedro T Ochoa, Evelyn S Sanchez-Hernandez, Alfonso M Duran

|Apr 13, 2024
A Stem-like Patient-Derived Ovarian Cancer Model of Platinum Resistance Reveals Dissociation of Stemness and Resistance.

Tise Suzuki, Ashlyn Conant, Yeonkyu Jung

|Oct 14, 2023
Racial and Ethnic Disparities in Gynecologic Carcinosarcoma: A Single-Institution Experience.

Kristina E Mercado, Nora M Badiner, Canty Wang

Pageof 2

Frequent Collaborators

3 joint publications

Evgeny Chirshev

2 joint publications

Hanmin Wang

2 joint publications

Tise Suzuki

2 joint publications

Charles Wang